Sorbitol

Sorbitol

SCHEMBL5801966

O=C([O-])[O-].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO.[Ca+2]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Sorbitol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
TDP1 Q9NUW8 1/20 0.61
PDE4A P27815 1/20 0.56
USP2 O75604 1/20 0.52
SLCO1B1 Q9Y6L6 1/20 0.52
KDM4E B2RXH2 2/20 0.44
OR51E2 Q9H255 1/20 0.35
MAPT P10636 1/20 0.32
CA4 P22748 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
TOP1 P11387 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mannitol SCHEMBL27515859 1.00 LMNA (0.65) LMNAL3MBTL1TDP1PDE4AUSP2
Mannitol SCHEMBL27645017 0.94 LMNA (0.73) LMNAL3MBTL1TDP1PDE4AUSP2
Adonitol SCHEMBL27558452 0.94 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AUSP2
Sorbitol SCHEMBL2122836 0.94 LMNA (0.65) LMNAL3MBTL1TDP1PDE4AUSP2
Mannitol SCHEMBL27797259 0.90 LMNA (0.56) LMNAL3MBTL1TDP1PDE4AUSP2
Xylitol SCHEMBL2123188 0.88 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AUSP2
Gluconic Acid SCHEMBL28437085 0.88 LMNA (0.87) LMNAL3MBTL1TDP1PDE4AUSP2
Gluconic Acid SCHEMBL28860760 0.86 PDE4A (0.83) LMNAL3MBTL1TDP1PDE4AUSP2
Gluconic Acid SCHEMBL27868062 0.86 PDE4A (0.83) LMNAL3MBTL1TDP1PDE4AUSP2
Mannitol SCHEMBL27789598 0.86 LMNA (0.77) LMNAL3MBTL1TDP1PDE4AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017100656-A1 DRY POWDER FORMULATIONS OF ASPIRIN FOR INHALATION OTITOPIC INC. (US) 2017-06-15 WO disclosed
WO-2006082596-A2 NEEM OIL CONTRACEPTIVE FORMULATIONS SINGH KAMALINDER KAUR (IN) 2006-08-10 WO disclosed
US-20060135613-A1 Carboxamides derivatives BAYER HEALTHCARE AG (DE) 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135613-A1 Carboxamides derivatives BPHL, HRH2, HRH4 LMNA 1869/4885L3MBTL1 4574/4885TDP1 4168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.